These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35280723)

  • 61. Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery.
    Wan XB; Zhang Q; Chen M; Liu Y; Zheng J; Lan P; He F
    Front Oncol; 2020; 10():1280. PubMed ID: 32974129
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes.
    DI Tommaso M; Rosa C; Caravatta L; Augurio A; Borzillo V; DI Santo S; Perrotti F; Taraborrelli M; Cianci R; Innocenti P; DI Sebastiano P; Colasante A; Angelucci D; Basti M; Sindici G; Mazzola L; Pizzicannella G; DI Bartolomeo N; Marchioni M; DI Nicola M; Genovesi D
    In Vivo; 2020; 34(3):1223-1233. PubMed ID: 32354913
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
    Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
    Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
    Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
    World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial.
    Hu YH; Wei JW; Chang H; Xiao WW; Lin JZ; Cai MY; Cai PQ; Kong LH; Chen G; Pan ZZ; Zeng ZF; Ding PR; Gao YH
    Cancer Manag Res; 2018; 10():4363-4369. PubMed ID: 30349369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P; Wang Z; Liu Y; Xie J; Ren Y
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer.
    Rengo M; Picchia S; Marzi S; Bellini D; Caruso D; Caterino M; Ciolina M; De Santis D; Musio D; Tombolini V; Laghi A
    Oncotarget; 2017 Dec; 8(70):114746-114755. PubMed ID: 29383117
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Medicine (Baltimore); 2016 Jan; 95(3):e2272. PubMed ID: 26817863
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy.
    Yang H; Xing J; Zhang C; Yao Z; Wu X; Jiang B; Cui M; Su X
    Front Oncol; 2022; 12():1080475. PubMed ID: 36568169
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before surgery in patients with locally advanced rectal cancer.
    Azmy AM; Ghali RRY; Shakweer MM; Gobran NS; Soliman DA; Elhawi ME
    Cancer Treat Res Commun; 2022; 32():100604. PubMed ID: 35809530
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Sakin A; Sahin S; Sengul Samanci N; Yasar N; Demir C; Geredeli C; Erhan SS; Akboru MH; Cihan S
    J Oncol Pharm Pract; 2020 Oct; 26(7):1611-1620. PubMed ID: 32046577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.
    Velenik V; Ocvirk J; Music M; Bracko M; Anderluh F; Oblak I; Edhemovic I; Brecelj E; Kropivnik M; Omejc M
    Radiat Oncol; 2011 Aug; 6():105. PubMed ID: 21880132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
    Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
    World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
    Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
    Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
    World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.